Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Net Income of -$78.54 million for fiscal year 2025.
Corbus Pharmaceuticals Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$78.54M | -95.3% |
| 2024 | -$40.21M | +9.9% |
| 2023 | -$44.60M | -5.3% |
| 2022 | -$42.35M | +7.2% |
| 2021 | -$45.64M | +59.0% |
| 2020 | -$111.27M | -55.7% |
| 2019 | -$71.45M | -28.3% |
| 2018 | -$55.67M | -71.7% |
| 2017 | -$32.42M | -62.1% |
| 2016 | -$20.00M | -126.0% |
| 2015 | -$8.85M | -248.4% |
| 2014 | -$2.54M | -321.8% |
| 2013 | -$602.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$23.34M | -69.4% | -32.2% |
| June 30, 2025 | -$17.66M | -76.7% | -4.0% |
| March 31, 2025 | -$16.98M | -146.1% | -23.2% |
| September 30, 2024 | -$13.78M | -37.1% | -37.9% |
| June 30, 2024 | -$10.00M | -13.8% | -44.9% |
| March 31, 2024 | -$6.90M | +61.1% | +31.4% |
| September 30, 2023 | -$10.05M | -14.5% | -14.4% |
| June 30, 2023 | -$8.78M | +33.7% | +50.5% |
- Corbus Pharmaceuticals Holdings, Inc. showed a decrease of -95.3% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Corbus Pharmaceuticals Holdings, Inc.’s net income has declined by 12938.4% (from -$602.4 thousand to -$78.54 million).
- The most recent figure is from Corbus Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: